Metraipolis › archive › dc_7e0bf8b0c2bb
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40906750
- DOI
- 10.1371/journal.pone.0328305
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:52:32.130Z
- SHA-256 of the archived text
322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b- Stable URL of this page
https://metraipolis.com/documento/dc_7e0bf8b0c2bb
How to cite
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750 — Europe PMC (en), https://europepmc.org/article/MED/40906750 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e0bf8b0c2bb (Metraipolis archive dc_7e0bf8b0c2bb, sha256 322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b)
BibTeX
@misc{dc7e0bf8b0c2bb,
title = {A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy — Europe PMC PMID:40906750},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40906750},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e0bf8b0c2bb; sha256 322db2809e741e35e73f8a29aff223502709c841f4e6cf948801920d8215f03b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40906750. Agents can read the archived copy with the MCP tool read_document.